A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05735366 · COMPLETED
Trial details
- NCT number
- NCT05735366
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2026-01-26
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.